Watanabe T, Soeda S, Nishiyama H, Kiko Y, Tokunaga H, Shigeta S, Yaegashi N, Yamada H, Ohta T, Nagase S, Shoji T, Kagabu M, Baba T, Shimizu D, Sato N, Terada Y, Futagami M, Yokoyama Y, Fujimori K. Clinical and reproductive outcomes of fertility-sparing surgery in stage I epithelial ovarian cancer. Mol Clin Oncol. 2020;12(1):44-50.
Horikawa N, Abiko K, Matsumura N, Baba T, Hamanishi J, Yamaguchi K, Murakami R, Taki M, Ukita M, Hosoe Y, Koshiyama M, Konishi I, Mandai M. Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment. Br J Cancer. 2020; 122(1):778-788
Kuwahara R, Kido A, Yajima R, Nishio N, Nakao K, Kurata Y, Tanaka S, Minamiguchi S, Baba T, Mandai M, Togashi K. Microcystic, Elongated and Fragmented Pattern Invasion Can Adversely Influence Preoperative Staging for Low-grade Endometrial Carcinoma. Magn Reson Med Sci. 2020 Feb 19[Online ahead of print]
Onoue H, Baba T, Koiwa K, Kon M, Ikeda M, Kumagai J. Clinical relevance of endometrial polyps diagnosed by hysteroscopy in 613 infertile women: a retrospective, single-center, cohort study. Obstet Gynecol Int J. 2020;11(3):137-141. DOI: 10.15406/ogij.2020.11.00500
Onoue H, Baba T, Koiwa K, Kon M, Tsuchiya S, Sato C. Treatment outcomes of intrauterine insemination and pregnancy prognosis factors: a retrospective single-center cohort study. Int J Fam Commun Med. 2020;4(3):78-81. DOI: 10.15406/ijfcm.2020.04.00189
Matsuoka H, Murakami R, Abiko K, Yamaguchi K, Horie A, Hamanishi J, Baba T, Mandai M. UGT1A1 polymorphism has a prognostic effect in patients with stage IB or II uterine cervical cancer and one or no metastatic pelvic nodes receiving irinotecan chemotherapy: a retrospective study. BMC Cancer. 2020 Aug 5;20(1):729.
Sasaki Y, Ito K, Fukumoto K, Kawamura H, Oyama R, Sasaki M, Baba T. Cerebral diffusion kurtosis imaging to assess the pathophysiology of postpartum depression. Sci Rep. 2020;10(1):15391.
Huang Z, Kondoh E, Visco Z, Baba T, Matsumura N, Dolan E, Whitaker RS, Konishi I, Fujii S, Berchuck A, Murphy SK. Targeting dormant ovarian cancer cells in vitro and in an in vivo mouse model of platinum resistance. Mol Cancer Ther. 2020 Oct 9:molcanther.0119.2020.
Sato C, Osakabe M, Nagasawa T, Suzuki H, Itamochi H, Baba T, Sugai T. Genome-wide analysis of microRNA to evaluate prognostic markers in isolated cancer glands and surrounding stroma in high-grade serous ovarian carcinoma. Oncol Lett. 2020;20(6):338.
Kagabu M, Yoshino N, Saito T, Miura Y, Takeshita R, Murakami K, Kawamura H, Baba T, Sugiyama T. The efficacy of a third-generation oncolytic herpes simplex viral therapy for an HPV-related uterine cervical cancer model. Int J Clin Oncol. 2020. doi: 10.1007/s10147-020-01823-6.
Horie A, Abiko K, Baba T, Sunada M, Kitamura S, Yamanoi K, Horikawa N, Yamaguchi K, Hamanishi J, Kondoh E, Mandai M. A novel direct approach to the deep uterine vein in laparoscopic radical hysterectomy. J Minim Invasive Gynecol. 2020:S1553-4650(20)31192-4.
Natori N, Haba G, Kawamura H, Terata M, Isurugi C, Sasaki Y, Hatayama S, Oyama R, Baba T. Evaluation of Normal Fetal Heart Function by Novel Obstetrics Ultrasound. Clinics Mother Child Health 2020; 17(2):344. (0.432)
Terata M, Oyama R, Kikuchi K, Kogita K, Okada Y, Kawamura H, Haba G, Hatayama S, Isurugi C, Baba T. Magnetic Resonance Imaging and Diffusion-weighted magnetic resonance imaging of Cornelia de Lange syndrome. JCBPS Section B 2021;1-7 (1.457)
Kobayashi E, Kanao H, Takekuma M, Nishio S, Kojima-Chiba A, Tozawa A, Yamaguchi S, Takeshima N, Nakatani E, Mikami M. A retrospective assessment of the safety and efficacy of laparoscopic radical hysterectomy in Japan during the early years following its introduction: a Japanese Gynecologic Oncology Group study (JGOG1081S) Int J Clin Oncol. 2021;26(2):417-428
Watanabe T, Soeda S, Nishiyama H, Kiko Y, Tokunaga H, Shigeta S, Yaegashi N, Yamada H, Ohta T, Nagase S, Shoji T, Kagabu M, Baba T, Shimizu D, Sato N, Terada Y, Futagami M, Yokoyama Y, Fujimori K. Clinical and reproductive outcomes of fertility-sparing surgery in stage I epithelial ovarian cancer. Mol Clin Oncol. 2020;12 (1):44-50
Shoji T, Takatori E, Kagabu M, Futagami Y, Yokoyama Y, Tokunaga H, Yaegashi N, Ohta T, Watanabe T, Sugiyama T. Relationship between usefulness of irinotecan and pegylated liposomal doxorubicin therapy and the UGT1A1 genotype in patients with recurrent ovarian cancer (TGCU 104 study) Eur J Gynaecol Oncol 2020; 41: 380-5
Takeuchi S, Kagabu M, Shoji T, Nitta Y, Sugiyama T, Sato J, Nakamura Y. Anti-cancer immunotherapy using cancer-derived multiple epitope-peptides cocktail vaccination clinical studies in patients with refractory/persistent disease of uterine cervical cancer and ovarian cancer [phase 2]. Oncoimmunology 2020; 9: No1
Soma R, Shoji T, Sato C, Tomabechi H, Nagasawa T, Kagabu M, Baba T. Successful treatment with CPT-11 plus S-1 therapy in a patient with primary signet-ring cell carcinoma of the uterine cervix: A case report and literature review. European Journal of Gynaecological Oncology 41 (6), 868-872
Kagabu M, Nagasawa T, Sato C, Fukagawa Y, Kawamura H, Tomabechi H, Takemoto S, Shoji T, Baba T. Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future Directions. International journal of molecular sciences 21 (7), 2335
Onoue H, Baba T, Koiwa K, Kon M, Ikeda M, Kumagai J. Clinical relevance of endometrial polyps diagnosed by hysteroscopy in 613 infertile women: a retrospective, single-center, cohort study.Obstet Gynecol Int J. 2020 ; 11(3) : 137-141
Onoue H, Baba T, Koiwa K, Kon M, Tsuchiya S, Sato C. Treatment outcomes of intrauterine insemination and pregnancy prognosis factors: a retrospective single-center cohort study.Int J Fam Commun Med. 2020 ; 4(3) :78-81
Terata M, Oyama R, Kikuchi K, Kogita K, Okada Y, Kawamura H, Haba G, Hatayama S, Isurugi C, Baba T. Magnetic Resonance Imaging and Diffusion-weighted magnetic resonance imaging of Cornelia de Lange syndrome. JCBPS Section B; November 2020 January 2021:1-7
英文症例報告
Shoji T, Takeshita R, Saito T, Aida T, Sasou S, Baba T. A case of primary ovarian signet-ring cell carcinoma treated with S-1/CDDP therapy. J Ovarian Res. 2020;13(1):33.
Fukagawa Y, Itamochi H, Sato C, Tomabechi H, Nagasawa H, Kagabu M, Shoji T, Sugai T, Baba T. Primary y ovarian serous psammocarcinoma-a case report with mini literature review. Obstet Gynecol Int J.2020;11(3):192-195. DOI: 10.15406/ogij.2020.11.00508
Nakamura M, Murakami R, Abiko K, Miyamoto T, Kitawaki Y, Yamaguchi K, Horie A, Hamanishi J, Kodoh E, Baba T, Kido A, Minamiguchi S, Matsumura N, Mandai M. Low-Grade Endometrial Stromal Sarcoma with a Nodule-in-Nodule Appearance in Preoperative Magnetic Resonance Images. Case Rep Obstet Gynecol. 2020 Jul 30;2020:8973262.
Hisano M, Kato R, Itamochi H, Matsuura T, Maekawa S, Kato Y, Kanehira M, Takata R, Baba T, Obara W. Rapid progression of recurrent disease in a patient with renal cell carcinoma with vaginal metastasis. IJU Case Rep. 2020; 3: 185-188
Sugimoto R, Yanagawa N, Osakabe M, Uesugi N, Ito Y, Fukagawa D, Baba T, Sugai T. Epiploic appendage infarction of the sigmoid colon. Pathol Int. doi: 10.1111/pin.13019.
Kagabu M, Nagasawa T, Sato C, Fukagawa Y, Kawamura H, Tomabechi H, Takemoto S, Shoji T, Baba T. Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future Directions. Int J Mol Sci. 2020 27; 21(7).
Terata M, Oyama R, Kikuchi K, Kogita H, Okada Y, Kawamura H, Haba G, Hatayama S, Isurugi C, Baba T. Magnetic Resonance Imaging and Diffusion-weighted magnetic resonance imaging of Cornelia de Lange syndrome. JCBPS; Section B. 2021; 11(1): 1-7. DOI:10.24214/jcbps.B.11.1.00107.
Soma R, Shoji T, Sato C, Tomabechi H, Nagasawa T, Kagabu M, Baba T. Successful treatment with CPT-11 plus S-1 therapy in a patient with primary signet-ring cell carcinoma of the uterine cervix : A case report and literature review. Eur J Gynaecol Oncol; 2020: 41, 868-72.
英文総説
Natori N, Haba G, Kawamura H, Terata M, Isurugi C, Sasaki Y, Hatayama S, Oyama R, Baba T. Evaluation of Normal Fetal Heart Function by Novel Obstetrics Ultrasound. Clinics Mother Child Health. 2020;17(2):344.
Kagabu M, Nagasawa T, Sato C, Fukagawa Y, Kawamura H, Tomabechi H, Takemoto S, Shoji T, Baba T. Immunotherapy for uterine cervical cancer using checkpoint inhibitors: future directions. Int. J. Mol. Sci. 2020, 21, 2335.
Kawaguchi R, Matsumoto K, Ishikawa T, Ishitani K, Okagaki R, Ogawa M, Oki T, Ozawa N, Kawasaki K, Kuwabara Y, Koga K, Sato Y, Takai Y, Tanaka K, Tanebe K, Terauchi M, Todo Y, Nose-Ogura S, Noda T, Baba T, Fujii E, Fujii T, Miyazaki H, Yoshino O, Yoshimura K, Maeda T, Kudo Y, Kobayashi H. Guideline for Gynecological Practice in Japan: Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists 2020 edition. J Obstet Gynaecol Res. 2020 Nov 4. doi: 10.1111/jog.14487.
Kagabu M, Nagasawa T, Sato C, Fukagawa Y, Kawamura H, Tomabechi H, Takemoto S, Shoji T, BabaT. Immunotherapy for uterine cervical cancer using checkpoint inhibitors: future directions. Int. J. Mol. Sci. 2020, 21, 2335.
Baba T. The global situation- From Asia. FIGO MAS Committee Webinar. “Re starting elective surgery during the COVID 19 health crisis - A global perspective” 2020/07/22
Baba T. Current problems in MIGS. AOFOG Oncology Committee and MIGS Committee Webinar. “COVID-19 and Gynaecological Cancer Management” 2020/07/26 co-moderated with Prof. Sarikapan Wilailak.
Baba T. Tips for safe TLH. Gynecological Endoscopic Society of Bangladesh Webinar. “Road to Recovery ? Returning of Endoscopic Surgeries” 2020/08/23
Oral presentation
Baba T, Koshiyama M, Minamiguchi S, Mikami Y, Moritani S, Ishikawa M, Konishi I, Yaegashi N. Clinicopathologic features of ovarian serous borderline tumors with recurrence or extraovarian lesions; a retrospective multi-intuitional study of Japan Clinical Oncology Group (JCOG).17th Biennial Meeting of the International Gynecologic Cancer Society. 2018. Kyoto
Baba T. MIGS committee’s plan: Prevail MIGS more! Proceed MIGS safer! Prospect MIGS’ Future! AOFOG Acton Plan Meeting. 2020. Luang Prabang, Laos.
一般講演
Nishikawa N, Shoji T, Enomoto T, Abe M, Okamoto A, Saito T, Oishi T, Nagase S, Mori M, Inokuchi Y, Kamiura S, Sugiyama T. Phase II Trial Evaluating Efficacy and Safety of Standard of Care With or Without Bevacizumab in Platinum-resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: JGOG3023 (Plenary Sessions).19th Biennial Meeting of the International Gynecologic Cancer Society.2020.Rome.web.
Ishikawa M, Kitagawa R, Shibata T, Tokunaga H, Iwata T, Nishio S, Takada T, Mori M, Horie K, Kudaka W, Kagabu M, Tanikawa M, Kobayashi H, Yaegashi N. A randomized phase II/III trial of conventional paclitaxel and carboplatin with/without bevacizumab versus dose-dense paclitaxel and carboplatin with/without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinoma (JCOG1311): Results of the phase II part. ASCO annual meeting 2020.2020.6.Chicago.
Sato C, Osakabe M, Suzuki H, Itamochi H, Baba T, Sugai T. Global microRNA expression in isolated cancer glands and surrounding stroma in high-grade serous ovarian carcinoma.第79回日本癌学会学術集会.2020年10月.広島.WEB開催